Analysis Innovative MedTech Inc. (IMTH)
5/29/2024
Analysis of Innovative MedTech Inc. (IMTH)
Innovative MedTech Inc. (IMTH) has shown a consistent price of around 0.6 to 0.62 over the past few days. The Relative Strength Index (RSI) indicates that the stock is not currently overbought or oversold, hovering around 28 to 32. The Moving Average Convergence Divergence (MACD) indicator shows a negative trend, with the MACD line below the signal line.The Moving Average (MA) indicator suggests a downward trend, with the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) all showing values below the current price.
Overall, based on the indicators, it seems that IMTH is currently in a consolidation phase with a slightly bearish bias. Traders and investors may want to monitor the stock for potential breakout or reversal signals before making any trading decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The results for the quarter ending on January 31, 2025, were released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.
Moving on to stock statistics, the company has a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The average 10-day volume is 52.90 million shares, while the average 90-day volume is 62.82 million shares. The stock has a market capitalization of $2.91 trillion.
Valuation metrics show a PEG ratio of 26.21, forward P/E of 26.21, and trailing P/E of 29.43. The enterprise value is $2.95 trillion, with a price-to-book ratio of 39.18 and price-to-sales ratio of 7.62. The stock has an enterprise-to-EBITDA ratio of 22.75 and an enterprise-to-revenue ratio of 7.73.
The stock price summary includes a beta of 1.26, a 50-day moving average of $173.69, and a 200-day moving average of $180.79. The stock's 52-week low is $164.08, the high is $199.62, and the change over the past 52 weeks is 8.25%.
Lastly, in terms of dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The stock's ex-dividend date is May 10, 2024, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73% and the trailing annual dividend yield is 0.51%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in sales from FY 2022 to FY 2023.
- Prior to the decrease, there was a consistent growth in sales from FY 2020 to FY 2022.
- FY 2022 had the highest sales figure among the four fiscal years.
- There was a significant increase in sales from FY 2020 to FY 2021.
These trends indicate fluctuations in the company's revenue over the years, with both growth and decline periods.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist of investments, machinery, and other assets, with investments and advances being a significant portion.
4. Total liabilities have also been increasing, with the highest value of $302,083,000,000 in 2022.
5. Current liabilities include short-term debt, accounts payable, and other current liabilities.
6. Non-current liabilities comprise long-term debt and other non-current liabilities.
7. Shareholders' equity has shown variations, with the highest value of $90,488,000,000 in 2019.
8. Common stock and retained earnings are part of shareholders' equity.
9. The company seems to be investing heavily in non-current assets and managing its liabilities effectively.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant cash outflows, mainly due to common stock repurchases and dividend payments.
6. Investing activities have also seen significant cash flows, with the company making investments and acquisitions while also divesting assets.
7. Overall, the company's financial performance seems to be stable, with strong cash flows from operating activities supporting its financial position.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter a year ago.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This suggests a potential increase from the EPS of $6.59 from the previous year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. The current year growth rate is estimated to be 7.5%.
2. The next quarter growth rate is projected to be 4.8%.
3. The current quarter growth rate is expected to be 5.6%.
4. The next year growth rate is forecasted to be 9.7%.
5. The average annual growth rate for the next 5 years is estimated to be 11%.
6. The average annual growth rate for the past 5 years was approximately 20.15%.
These estimates suggest that the company is expected to experience moderate growth in the short term, with a slightly higher growth rate projected for the next year. However, the average annual growth rate over the next 5 years is expected to be higher, indicating a more optimistic outlook for the company's long-term performance compared to the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of expectations for the future price of the security, with the median and average both indicating a price higher than the current value. The low and high ends of the forecast suggest a potential price range within which the security may trade in the future.
MACD of IMTH
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
